2014-08-14T14:03:26-05:00 2013-12-31 560747981 DIXON HUGHES GOODMAN LLP 701 TOWN CENTER DRIVE SUITE 700 NEWPORT NEWS VA 236064295 990 2013-01-01 541839226 NATIONAL PATIENT ADVOCATE FOUNDATION NATI 7579521369 421 BUTLER FARM ROAD HAMPTON VA 23666 ALAN BALCH CHIEF EXECUTIVE OFFICER 7578736668 2014-08-14 1 JAMES M HAGGARD P00100566 7578731033 2013 2015-11-30 17:44:51Z ALAN BALCH 421 BUTLER FARM ROAD HAMPTON VA 23666 2650953 0 X WWW.NPAF.ORG X 1996 VA NATIONAL PATIENT ADVOCATE FOUNDATION IS A NATIONAL NONPROFIT ORGANIZATION THAT SEEKS TO CREATE AVENUES OF ACCESS TO HEALTHCARE SERVICES INCLUSIVE OF REIMBURSEMENT VEHICLES FOR PHYSICIANS, IMAGING SERVICES, EVOLVING THERAPIES, THERAPEUTIC DEVICES AND AGENTS THROUGH LEGISLATIVE REFORM. 15 13 13 3796 0 0 1460410 1260713 1263750 1387500 2992 2740 0 0 2727152 2650953 5000 10000 0 0 1019112 1225198 0 0 20203 1674476 1401121 2698588 2636319 28564 14634 1224600 1749914 684502 1195182 540098 554732 X NPAF IS A NONPROFIT ORGANIZATION WHICH SEEKS TO CREATE AVENUES OF ACCESS TO AND REIMBURSEMENT FOR EVOLVING THERAPIES, THERAPEUTIC DEVICES AND AGENTS THROUGH LEGISLATIVE AND POLICY REFORM. 0 0 964166 1090000 THE OBJECTIVE OF THE POLICY CONSORTIUM IS TO PROVIDE A FORUM FOR INTERESTED HEALTHCARE STAKE HOLDERS TO EXPLORE REGULATORY AND LEGISLATIVE ISSUES OF MUTUAL INTERESTS AND TO DISCUSS COLLABORATIVEPROCESSES TO HANDLE THOSE ISSUES. NATIONAL PATIENT ADVOCATE FOUNDATIONS POLICY CONSORTIUM MEETINGS, WHICH OCCUR TWICE ANNUALLY, INCLUDE KEYNOTE SPEAKERS FROM NATIONAL RESEARCH ENTITIES, FEDERAL REGULATORY AGENCIES, FEDERAL LEGISLATIVE REPRESENTATIVES, ADMINISTRATIVE OFFICALS, STATE LEGISLATIVE AND REGULATORY REPRESENTATIVES, SPECIALTY CONSULTANTS, NATIONAL NON-PROFIT PATIENT REPRESENTATIVES, NATIONAL ACADEMIC LEADERS, NATIONAL HEALTHCARE MEDIA EXPERTS AND SUBJECT MATTER EXPERTS. THE POLICY CONSORTIUM MEETING FORMAT SEEKS TO ELICIT NEW IDEAS AND STIMULATE MUTUAL COLLABORATION OUTLINING POSITIVE STEPS TO POSITIVE CHANGES. THE POLICY CONSORTIUM MEETS TWICE YEARLY IN WASHINGTON D.C. IN MAY AND NOVEMBER. ADDITIONALLY, NEWSLETTERS ARE PROVIDED. ANNUAL MEMBERSHIP DUES ARE REQUIRED FOR PARTICIPATION IN THE POLICY CONSORTIUM. 802738 10000 297500 NPAF IS FOCUSED ON CREATING FORUMS INCLUSIVE OF A BROAD ARRAY OF STAKEHOLDERS FROM THE HEALTHCARE COMMUNITIES ALL WITH THE GOAL OF EDUCATING REGULATORY AND LEGISLATIVE BODIES AT BOTH THE STATE AND NATIONAL LEVELS. NPAF HAS DEVELOPED THREE STRATEGIES FOR ACCOMPLISHING THIS GOAL INCLUDING THE REGULATORY EDUCATION AND ACTION FOR PATIENTS (REAP) INITIATIVE, PATIENT ASSISTANCE LEAGUE (PAL) AND THE DIRECT REPRESENTATION OF THE LEGISLATIVE INTERESTS OF ITS SISTER ORGANIZATION, PATIENT ADVOCATE FOUNDATION (PAF). PAF IS A NATIONAL NON-PROFIT 501(C)(3) ORGANIZATION THAT SEEKS TO SAFEGUARD PATIENTS THROUGH EFFECTIVE MEDIATION ASSURING ACCESS TO CARE, MAINTENANCE OF EMPLOYMENT AND PRESERVATION OF THEIR FINANCIAL STABILITY RELATIVE TO THEIR DIAGNOSIS OF LIFE THREATENING OR DEBILITATING DISEASES. NPAF SERVES AS THE POLICY VOICE FOR PAF AND THE CONSTITUENCIES SERVED BY PAF.CREATED IN 2010 BY NPAF, THE REGULATORY EDUCATION AND ACTION FOR PATIENTS INIATIVE (REAP) IS AN UMBRELLA EDUCATIONAL INITIATIVE AND COALITION COMPOSED OF 63 PATIENT ADVOCACY MEMBER ORGANIZATIONS. THE GOAL OF REAP IS TO STRENGTHEN CURRENT RELATIONSHIPS AND BUILD NEW RELATIONSHIPS WITH GOVERNMENT AGENCIES THAT ARE RESPONSIBLE FOR IMPLEMENTING PROVISIONS OF THE PATIENT PROTECTION AND AFFORDABLE CARE ACT (PPACA) AND OTHER RELATED REGULATORY CHANGES THROUGH DRAFTING COMMENT LETTERS TOGETHER IN RESPONSE TO PROPOSED RULES. REAP HAS A FURTHER GOAL OF ENSURING THAT IMPLEMENTATION OF THESE PROVISIONS ARE PATIENT-CENTRIC. REAPS MISSION IS TO COMMUNICATE THE PATIENT PERSPECTIVE ON ISSUES TO FEDERAL AND STATE REGULATORY BODIES, CONGRESS, HEALTH CARE INSURERS AND OTHERS THAT REGULATE/DEVELOP/MANAGE AND/OR IMPACT HEALTH CARE DELIVERY, COVERAGE, COST AND AVAILABILITY TO THE UNITED STATES POPULATION.REAP CONVENES MEETINGS WITH ITS MEMBER ORGANIZATIONS TO EDUCATE THEM ON PROPOSED RULES WITHIN PPACA AND OTHER ISSUES AND TO BUILD CONSENSUS ON HOW REAP AS A GROUP WILL RESPOND VIA THE DEFINED FEDERAL REGULATORY COMMENT PROCESS. NATIONAL PATIENT ADVOCATE FOUNDATION STAFF REVIEW ALL OF THE REQUESTS FOR COMMENTS THAT ARE POSTED ON THE FEDERAL REGISTER TO DETERMINE WHICH PROPOSED RULES WOULD HAVE AN IMPACT ON PATIENTS THAT ARE SERVED BY REAP MEMBERS. COMMENTS ARE DRAFTED AND THEN PROVIDED TO ALL MEMBERS FOR THEIR REVIEW. REAP MEMBERS THEN MEET VIA CONFERENCE CALL TO REVIEW DRAFT COMMENTS PRIOR TO THEIR DELIVERY. AS OF DECEMBER 2013, REAP HAS SUBMITTED 15 JOINT LETTERS VIA THE REGULATORY COMMENT PROCESS.LASTLY, THE NPAF STATE GOVERNMENT AFFAIRS PROGRAM ENGAGES IN PROACTIVE ADVOCACY EFFORTS IN STATE LEGISLATURES AND IN THE STATE REGULATORY PROCESS ON BEHALF OF PATIENTS AND THEIR FAMILIES ON AN ONGOING BASIS. A MAJOR PART OF NPAF STATE GOVERNMENT AFFAIRS EFFORTS ARE THE NPAF VOLUNTEERS, WHO CONTRIBUTE TO THE SUCCESS OF NPAF IN EACH STATE. THE ELITE PRESIDENTS COUNCIL SERVES AS THE TOP TIER OF THE NPAF VOLUNTEER STRUCTURE AND IS COMPRISED OF INDIVIDUALS WHO ARE INTIMATELY INVOLVED IN THE POLITICAL PROCESSES AND PATIENT COMMUNITIES IN THEIR STATES. THE PATIENT ACTION LEAGUE (PAL), ESTABLISHED IN 2012, IS THE PRIMARY COMMUNICATION AND EDUCATIONAL CHANNEL OF THE ELITE PRESIDENTS COUNCIL AND OFFERS ELITE VOLUNTEERS A FORUM FOR DISCUSSION AND ACTION PLANNING. THE PURPOSE OF THE LEAGUE IS TO PROVIDE ELITE PRESIDENTS COUNCIL VOLUNTEERS WITH AN OUTSTANDING EDUCATIONAL OPPORTUNITY IN THEIR SPECIFIC REGION OF THE COUNTRY TO GIVE THEM THE INFORMATION, INSIGHT AND MOTIVATION NEEDED TO ACCOMPLISH THE FOLLOWING:PARTICIPATE IN ESSENTIAL STATE ADVOCACY EFFORTS THAT WILL PROVIDE BENEFIT TO PATIENTSBUILD UPON THEIR EFFECTIVENESS IN WORKING WITH COALITIONS, OTHER GROUPS AND ADVOCACY PARTNERS IN THE PURSUIT OF GOOD PUBLIC POLICY THAT WILL ADDRESS THE NEEDS OF PATIENTS.EMPOWER NPAF ELITE PRESIDENTS COUNCIL MEMBERS TO RECRUIT/ASSIST NEW VOLUNTEERS IN BUILDING GRASSROOTS ADVOCACY NETWORKS TO PROVIDE A POWERFUL AND EFFECTIVE VOICE IN OUR STATE CAPITOLS.PAL HOSTS REGIONAL MEETINGS THROUGHOUT THE COUNTRY EACH WITH THE CRITICAL OBJECTIVES TO EDUCATE AND INFORM PATIENTS, TO ALLOW A VIBRANT EXCHANGE OF INFORMATION BETWEEN VOLUNTEERS, ADVOCACY PARTNERS AND HEALTHCARE PARTNERS ABOUT ISSUES OF CRITICAL IMPORTANCE FOR PATIENTS IN EACH REGION AND MOST IMPORTANTLY, RESULT IN AN ANNUAL ACTION PLAN FOR THE REGION THAT INCORPORATES VOLUNTEER ADVOCACY FOR THE PURPOSE OF PROMOTING GOOD PUBLIC POLICY FOR PATIENTS. 505815 IN 2004, NPAF ESTABLISHED THE GLOBAL ACCESS PROJECT (GAP), A NEUTRALRESEARCH ENTITY WITH THE MISSION OF DESIGNING, MANAGING AND CARRYING OUT INDEPENDENT RESEARCH PROJECTS IN COLLABORATION WITH NATIONALLY RESPECTED AND RECOGNIZED EXPERTS IN SPECIFIC FIELDS OF HEALTH CARE. THE RESEARCH PROJECTS ARE DESIGNED TO PROVIDE SPECIFIC INFORMATION RELATIVE TO REIMBURSEMENT; ACCESS TO QUALITY HEALTHCARE; NATIONAL TRENDS IN ACCESS TO HEALTH CARE INCLUDING CLINICAL TRIALS; CHANGES IN TREATMENT SITES OF CARE; AND RESEARCH TO DEFINE DEFICIENCIES IN THE CURRENT CODING STRUCTURE OF REIMBURSEMENT. TO DATE, SEVEN STUDIES HAVE BEEN COMPLETED AND FINDINGS PRESENTED TO KEY OFFICALS IN THE ADMINISTRATION, CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS), MEDICARE PAYMENT ADVISORY COMMISSION(MEDPAC), AND CONGRESSIONAL COMMITTEES OF JURISDICTION ON HEALTHCARE. PROGRAM SERVICE ACCOMPLISHMENTS STUDIES ARE AVAILABLE FOR REVIEW ON WWW.NPAF.ORG. IN 2012, NPAF INITIATED THE EIGHTH RESEARCH STUDY THROUGH GAP. THE RESEARCH PROJECT, CONSUMER BASED CANCER CARE VALUE INDEX (CCCVI), IS BEING CONDUCTED BY AMERICAN INSTITUTES FOR RESEARCH (AIR) AND HAS AN EXPECTED DELIVERY DATE DURING THE LATTER PART OF 2014. 2272719 0 1 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 0 1 0 0 13 1 0 0 0 0 0 0 0 0 0 0 X 15 13 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 VA X X WILLIAM NASON 7579520592 421 BUTLER FARM ROAD HAMPTON VA 23666 ALAN J BALCH PHD CHIEF EXECUTIVE OFFICER 40.00 X X 65209 79700 8325 NANCY DAVENPORT-ENNIS SEE SCH O FOUNDER, CHAIRMAN OF THE BOARD 40.00 X X 99996 200672 12202 DENNIS A GASTINEAU MD BOARD PRESIDENT 5.00 X X 0 0 0 LEAH LOCKE-ARNETT BOARD SECRETARY 5.00 X X 0 0 0 CHRISTIAN G DOWNS JD MHA BOARD MEMBER, PAST PRESIDENT 5.00 X 0 0 0 PEARL MOORE RN MN FAAN BOARD MEMBER 5.00 X 0 0 0 JOHN L MURPHY BOARD MEMBER 5.00 X 0 0 0 LOVELL JONES PHD BOARD MEMBER 5.00 X 0 0 0 BRUCE AVERY MD BOARD MEMBER 5.00 X 0 0 0 JOHN CALDWELL CPA MST CGMA BOARD MEMBER 5.00 X 0 0 0 JOHN HARRINGTON BOARD MEMBER 5.00 X 0 0 0 DIANE MAUK BOARD MEMBER 5.00 X 0 0 0 OTIS MAYNARD ESQ BOARD MEMBER 5.00 X 0 0 0 ROBERT M RIFKIN MD FACP BOARD MEMBER 5.00 X 0 0 0 LORI WILLIAMS PHD MSN RN BOARD MEMBER 5.00 X 0 0 0 LARRY LANIER PRESIDENT, NPAF 40.00 X 187779 0 14634 LOU LAMARCA EVP, FEDERAL GOVERNMENT AFFAIRS 40.00 X 176051 0 18092 529035 280372 53253 2 0 1 0 AMERICAN INSTITUTES FOR RESEARCH 1000 THOMAS JEFFERSON ST NW WASHINGTON DC 20007 GLOBAL ACCESS PROJECT 454120 SCHMIDT PUBLIC AFFAIRS LLC 917 PRINCE STREET ALEXANDRIA VA 22314 ADVISOR 188029 ARENT FOX PLLC 1717 K STREET NW WASHINGTON DC 20036 REGULATORY ADVISOR 162354 KOUNTOUPES CONSULTING LLC 1333 H STREET NW SUITE 1100 WASHINGTON DC 20005 LEGISLATIVE ADVISOR 120000 4 510000 750713 1260713 MEMBERSHIP DUES - PROG 541900 1387500 1387500 1387500 2740 2740 2650953 1387500 0 2740 X 10000 10000 564088 462552 99844 1692 525392 422941 87740 14711 10059 8097 1680 282 38690 31146 6461 1083 86969 70010 14524 2435 6238 6238 12000 12000 724209 724209 195558 195558 84472 59130 25342 113631 79542 34089 143318 128986 14332 81196 73076 8120 5527 4974 553 2776 2498 278 DUES AND SUBSCRIPTIONS 32196 32196 2636319 2272719 343397 20203 200 200 1059041 1251565 90000 356325 300 43765 94522 99767 52765 31594 47002 1224600 1749914 649502 1105182 35000 90000 684502 1195182 X 540098 554732 540098 554732 1224600 1749914 14634 0 X X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 99767 52765 47002 47002 X 2658991 8038 8038 2650953 0 2650953 2644357 8038 8038 2636319 0 2636319 PART X, LINE 2: THE FOUNDATION IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(4) OF THE INTERNAL REVENUE CODE; ACCORDINGLY, THE ACCOMPANYING FINANCIAL STATEMENTS DO NOT REFLECT A PROVISION OR LIABILITY FOR FEDERAL AND STATE INCOME TAXES. THE FOUNDATION HAS DETERMINED THAT IT DOES NOT HAVE ANY MATERIAL UNRECOGNIZED TAX BENEFITS OR OBLIGATIONS AS OF DECEMBER 31, 2013 AND 2012. FISCAL YEARS ENDING ON OR AFTER DECEMBER 31, 2010 REMAIN SUBJECT TO EXAMINATION BY FEDERAL AND STATE TAX AUTHORITIES. 0 FRIENDS OF CANCER RESEARCH 1800 M STREET NW SUITE 1050 WASHINGTON DC 20036 521983273 501(C)(3) 10000 SUPPORT CANCER RESEARCH 1 0 X X X X X X 0 0 0 0 0 0 0 0 0 ALAN J BALCH PHD CHIEF EXECUTIVE OFFICER 65209 79700 0 0 0 0 0 1904 0 7028 65209 88632 0 0 NANCY DAVENPORT-ENNIS SEE SCH O FOUNDER, CHAIRMAN OF THE BOARD 99996 150672 0 50000 0 0 0 2701 0 10531 99996 213904 0 0 LARRY LANIER PRESIDENT, NPAF 187779 0 0 0 0 0 5724 0 10096 0 203599 0 0 0 LOU LAMARCA EVP, FEDERAL GOVERNMENT AFFAIRS 176051 0 0 0 0 0 5250 0 13983 0 195284 0 0 0 NANCY DAVENPORT-ENNIS CHAIRMAN OF THE BOARD/CO FOUNDER 510000 RELATED ENTITY - NANCY DAVENPORT-ENNIS IS THE CHAIRMAN OF THE BOARD OF NATIONAL PATIENT ADVOCATE FOUNDATION. SHE IS ALSO THE CHAIRMAN OF THE BOARD OF PATIENT ADVOCATE FOUNDATION, A SISTER ORGANIZATION OF NATIONAL PATIENT ADVOCATE FOUNDATION. NATIONAL PATIENT ADVOCATE FOUNDATION HAS A CONSULTING AGREEMENT WITH PATIENT ADVOCATE FOUNDATION IN WHICH PATIENT ADVOCATE FOUNDATION PAYS NATIONAL PATIENT ADVOCATE FOUNDATION FEES TO REPRESENT THE POLICY INTERESTS OF PAF. 0 ALAN BALCH CHIEF EXECUTIVE OFFICE RELATED ENTITY - ALAN BALCH IS THE CHIEF EXECUTIVE OFFICER OF NATIONAL PATIENT ADVOCATE FOUNDATION. HE IS ALSO THE CHIEF EXECUTIVE OFFICER OF PATIENT ADVOCATE FOUNDATION, A SISTER ORGANIZATION OF NATIONAL PATIENT ADVOCATE FOUNDATION. NATIONAL PATIENT ADVOCATE FOUNDATION HAS A CONSULTING AGREEMENT WITH PATIENT ADVOCATE FOUNDATION IN WHICH PATIENT ADVOCATE FOUNDATION PAYS NATIONAL PATIENT ADVOCATE FOUNDATION FEES TO REPRESENT THE POLICY INTERESTS OF PAF. 0 FORM 990, PART VI, SECTION A, LINE 2 JOHN L. MURPHY, BOARD MEMBER OF NATIONAL PATIENT ADVOCATE FOUNDATION IS THE BROTHER-IN-LAW OF NANCY DAVENPORT-ENNIS, CHAIRMAN OF THE BOARD OF NATIONAL PATIENT ADVOCATE FOUNDATION. FORM 990, PART VI, SECTION B, LINE 11 THE FINANCE COMMITTEE OF THE BOARD OF DIRECTORS RECEIVES A DRAFT COPY OF THE FORM 990 THEN SUBSEQUENTLY REVIEWS IT FOR ACCURACY AND COMPLIANCE. ONCE IT IS APPROVED BY THE FINANCE COMMITTEE, ALL MEMBERS OF THE EXECUTIVE BOARD OF DIRECTORS RECEIVE THE FINAL COPY OF THE FORM 990 FOR REVIEW AND APPROVAL AND IS SO NOTED IN THE BOARD MEETING MINUTES. FORM 990, PART VI, SECTION B, LINE 12C MEMBERS OF THE NPAF BOARD OF DIRECTORS ARE REQUIRED TO REVIEW AND SIGN THE CONFLICT OF INTEREST POLICY UPON ESTABLISHING MEMBERSHIP ON THE BOARD AND AGAIN ANNUALLY AT THE DIRECTION OF THE EXECUTIVE COMMITTEE. EACH MEMBER MUST DISCLOSE ANY/ALL KNOWN CONFLICTS OF INTEREST AT THAT TIME. IF ANY CONFLICTS OF INTEREST ARE NOTED MORE INFORMATION WILL BE GATHERED BY THE EXECUTIVE COMMITTEE AND A DETERMINATION ON THE EXISTENCE OF A MATERIAL CONFLICT WILL BE ISSUED. THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS IS CHARGED WITH ENFORCEMENT OF THIS POLICY. FORM 990, PART VI, SECTION B, LINE 15 NATIONAL PATIENT ADVOCATE FOUNDATION COMMISSIONS INDEPENDENT COMPENSATION STUDIES THAT UTILIZE NATIONAL COMPARABILITY DATA OF ORGANIZATIONS SIMILAR IN MISSION, SIZE AND REVENUES. NPAF HAS A COMPENSATION AND BENEFITS COMMITTEE WITHIN THE BOARD OF DIRECTORS THAT CONSISTS OF FOUR (4) EXECUTIVE BOARD MEMBERS AND IS CHAIRED BY THE BOARD PRESIDENT. THIS COMMITTEE IS PROVIDED WITH THE INDEPENDENTLY PRODUCED COMPENSATION REPORT AND UTILIZES IT TO ESTABLISH THE CEO'S ANNUAL COMPENSATION. THIS COMMITTEE ALSO REVIEWS THE COMPENSATION OF KEY EMPLOYEES UTILIZING THE COMPENSATION REPORT. THIS PROCESS IS DOCUMENTED THROUGH MINUTES OF THE COMPENSATION COMMITTEE MEETING. FORM 990, PART VI, SECTION C, LINE 19 NATIONAL PATIENT ADVOCATE FOUNDATION MAKES THEIR GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTING EXPENSE: INDEPENDENT STUDIES: PROGRAM SERVICE EXPENSES 441,855. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 441,855. CONSULTING EXPENSE: CERTIFIED CONSULTANT: PROGRAM SERVICE EXPENSES 282,354. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 282,354. FORM 990 - PART XII - LINE 2C THE FINANCE COMMITTEE REVIEWS AND APPROVES THE DRAFT OF THE AUDITED FINANCIAL STATEMENTS FOR ACCURACY AND COMPLIANCE. THE BOARD OF DIRECTORS RECEIVES THE FINAL COPY OF THE AUDITED FINANCIAL STATEMENTS WHEN IT IS COMPLETE AND APPROVED BY THE FINANCE COMMITTEE, SO NOTED IN THE MINUTES AND APPROVED BY THE BOARD. WHEN SELECTING A NEW AUDIT FIRM, NATIONAL PATIENT ADVOCATE FOUNDATION IDENTIFIES THREE RECOMMENDED REGIONAL FIRMS AND REQUESTS PROPOSALS FROM THEM. THE INFORMATION IS REVIEWED AND THE FINAL SELECTION IS APPROVED BY THE FINANCE COMMITTEE. PATIENT ADVOCATE FOUNDATION 421 BUTLER FARM ROAD HAMPTON VA 23666 541806317 ASSIST PATIENTS WITH GAINING FINANCIAL STABILITY AND ACCESS TO MEDICAL CARE. VA 501(C)(3) LINE 7 PATIENT ADVOCATE IS THE SISTER ORGANIZATION TO NATIONAL PATIENT ADVOCATE 0 0 0 1 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 0 PATIENT ADVOCATE FOUNDATION L 510000